3 Things About Abbott Laboratories That Smart Investors Know [The Motley Fool]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: The Motley Fool
Alex Carchidi(TMFacarchidi)Author BioAlex began writing for the Fool in early 00 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.Follow @alexcarchidiKey PointsWhen it comes to underrated healthcare stocks that smart investors love,Abbott LaboratoriesNYSE:ABTBut many investors may misunderstand the point of owning Abbott shares since many of its markets are decidedly niche. After all, selling goods like cardiac stents and Pedialyte might be profitable, but those products certainly don't seem like they'll ever face a gold rush of fresh demand. On the contrary, it's exactly Abbott's willingness to compete in these spaces that makes the company one of the sturdiest.So let's examine some key ways Abbott might stand out in the eyes of an experienced investor.Image s
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Drug Device Combination Products Market Worth Over $180 Billion by 2029 - Medtronic, Abbott Laboratories, and Boston Scientific Corporation Dominate the Industry [Yahoo! Finance]Yahoo! Finance
- R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO [Yahoo! Finance]Yahoo! Finance
- Pharmacogenomics Market Worth $19.5 billion by 2031 -- Exclusive Report by Meticulous Research® [Yahoo! Finance]Yahoo! Finance
- Drugmaker Abbott India posts Q4 profit rise on higher sales [Yahoo! Finance]Yahoo! Finance
- Drugmaker Abbott India posts Q4 profit rise on higher sales [Reuters]Reuters
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/10/24 - Form 144
- 5/8/24 - Form 4
- 5/7/24 - Form 144
- ABT's page on the SEC website